Paper42465249
Behavioral and Functional Profiling of Acomys cahirinus Fibroblasts Reveals Enhanced Matrix Remodeling Capacity.
Macaluso N and 6 others. bioRxiv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Behavioral and Functional Profiling of Acomys cahirinus Fibroblasts Reveals Enhanced Matrix Remodeling Capacity. Papers, record 42465249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42465249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Behavioral and Functional Profiling of Acomys cahirinus Fibroblasts Reveals Enhanced Matrix Remodeling Capacity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 OD028211 | NIH HHS | United States | R21OD028211 | PubMed | NIH RePORTER |
| R35 GM147788 | NIGMS NIH HHS | United States | R35GM147788 | PubMed | NIH RePORTER |
| R35 GM157099 | NIGMS NIH HHS | United States | R35GM157099 | PubMed | NIH RePORTER |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35456986 | Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35456986 | PubMed |
| 2 | 38831382 | Role of cellular senescence in inflammation and regeneration. | Inflamm Regen | 2024 | https://conductscience.org/library/papers/38831382 | PubMed |
| 3 | 27386492 | Introduction to machine learning: k-nearest neighbors. | Ann Transl Med | 2016 | https://conductscience.org/library/papers/27386492 | PubMed |
| 4 | 28967888 | Critical Assessment of Metagenome Interpretation-a benchmark of metagenomics software. | Nat Methods | 2017 | https://conductscience.org/library/papers/28967888 | PubMed |
| 5 | 31075413 | Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. | Gene | 2019 | https://conductscience.org/library/papers/31075413 | PubMed |
| 6 | 37751045 | Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation. | Geroscience | 2024 | https://conductscience.org/library/papers/37751045 | PubMed |
| 7 | 26989578 | Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. | Adv Wound Care (New Rochelle) | 2016 | https://conductscience.org/library/papers/26989578 | PubMed |
| 8 | 34507520 | CellProfiler 4: improvements in speed, utility and usability. | BMC Bioinformatics | 2021 | https://conductscience.org/library/papers/34507520 | PubMed |
| 9 | 39236902 | Type III Collagen Regulates Matrix Architecture and Mechanosensing during Wound Healing. | J Invest Dermatol | 2025 | https://conductscience.org/library/papers/39236902 | PubMed |
| 10 | 34849481 | Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome. | Matrix Biol Plus | 2021 | https://conductscience.org/library/papers/34849481 | PubMed |
| 11 | 25075903 | Improved vectors and genome-wide libraries for CRISPR screening. | Nat Methods | 2014 | https://conductscience.org/library/papers/25075903 | PubMed |
| 12 | 24409142 | Gradient boosting machines, a tutorial. | Front Neurorobot | 2013 | https://conductscience.org/library/papers/24409142 | PubMed |
| 13 | 26675084 | Evolution of cellular morpho-phenotypes in cancer metastasis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26675084 | PubMed |
| 14 | 35817510 | Cellular Senescence in Acute and Chronic Wound Repair. | Cold Spring Harb Perspect Biol | 2022 | https://conductscience.org/library/papers/35817510 | PubMed |
| 15 | 26780180 | Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/26780180 | PubMed |
| 16 | 31562333 | Connective tissue fibroblasts from highly regenerative mammals are refractory to ROS-induced cellular senescence. | Nat Commun | 2019 | https://conductscience.org/library/papers/31562333 | PubMed |
| 17 | 33424024 | A robust unsupervised machine-learning method to quantify the morphological heterogeneity of cells and nuclei. | Nat Protoc | 2021 | https://conductscience.org/library/papers/33424024 | PubMed |
| 18 | 26646499 | Cellular senescence in aging and age-related disease: from mechanisms to therapy. | Nat Med | 2015 | https://conductscience.org/library/papers/26646499 | PubMed |
| 19 | 19995679 | Fibroblasts and myofibroblasts in wound healing: force generation and measurement. | J Tissue Viability | 2011 | https://conductscience.org/library/papers/19995679 | PubMed |
| 20 | 26606282 | A Comparative Analysis of Gene Expression Profiles during Skin Regeneration in Mus and Acomys. | PLoS One | 2015 | https://conductscience.org/library/papers/26606282 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42465249
GET https://conductscience.org/api/papers/v1/42465249/references?page=2